Treatment may prevent Alzheimer's cognitive decline

A new study in mice found that a treatment involving antibodies to Dkk1, a protein linked to amyloid formation in Alzheimer's patients, may protect memory by stopping the disintegration of brain synapses. It won't be useful in people who already have advanced Alzheimer's disease but could potentially slow the rate of cognitive deterioration in those in the early stages of the disease.

View Full Article in:

Independent (London) (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Claims Director
PacificSource
Springfield, OR
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA